Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Treatment patterns for ductal carcinoma in situ with close or positive mastectomy margins.

Jones CE, Richman J, Jackson BE, Wallace AS, Krontiras H, Urist MM, Bland KI, Parker CC.

J Surg Res. 2018 Nov;231:36-42. doi: 10.1016/j.jss.2018.05.007. Epub 2018 Jun 1.

PMID:
30278953
2.

Impact of margin status on local recurrence after mastectomy for ductal carcinoma in situ.

Childs SK, Chen YH, Duggan MM, Golshan M, Pochebit S, Punglia RS, Wong JS, Bellon JR.

Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):948-52. doi: 10.1016/j.ijrobp.2012.07.2377. Epub 2012 Sep 11.

PMID:
22975615
3.

Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?

Fitzsullivan E, Lari SA, Smith B, Caudle AS, Krishnamurthy S, Lucci A, Mittendorf EA, Babiera GV, Black DM, Wagner JL, Bedrosian I, Woodward W, Gainer SM, Hwang R, Meric-Bernstam F, Hunt KK, Kuerer HM.

Ann Surg Oncol. 2013 Dec;20(13):4103-12. doi: 10.1245/s10434-013-3194-0. Epub 2013 Aug 23.

4.

The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.

Cassidy RJ, Liu Y, Kahn ST, Jegadeesh NK, Liu X, Subhedar PD, Arciero CA, Gillespie TW, Torres MA.

Cancer. 2017 Aug 1;123(15):2829-2839. doi: 10.1002/cncr.30675. Epub 2017 Apr 7.

5.

A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.

Truong PT, Olivotto IA, Speers CH, Wai ES, Berthelet E, Kader HA.

Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):797-804.

PMID:
14967436
6.
7.

Outcomes and utilization of postmastectomy radiotherapy for T3N0 breast cancers.

Francis SR, Frandsen J, Kokeny KE, Gaffney DK, Poppe MM.

Breast. 2017 Apr;32:156-161. doi: 10.1016/j.breast.2017.02.001. Epub 2017 Feb 10.

PMID:
28193571
8.

Postmastectomy radiation for N2/N3 breast cancer: factors associated with low compliance rate.

Chu QD, Caldito G, Miller JK, Townsend B.

J Am Coll Surg. 2015 Apr;220(4):659-69. doi: 10.1016/j.jamcollsurg.2014.12.045. Epub 2015 Jan 14.

PMID:
25797752
9.

Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.

Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J, Sigurdson E, Boraas M, Goldstein L.

Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):1005-15.

PMID:
10421533
10.

Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.

Rivera R, Banks A, Casillas-Lopez A, Rashtian A, Lewinsky B, Sheth P, Hovannesian-Larsen L, Brousseau D, Iyengar G, Holmes DR.

Breast J. 2016 Jan-Feb;22(1):63-74. doi: 10.1111/tbj.12516. Epub 2015 Nov 3.

PMID:
26534876
11.

Trends and variations in postmastectomy radiation therapy for breast cancer in patients with 1 to 3 positive lymph nodes: A National Cancer Data Base analysis.

Ohri N, Sittig MP, Tsai CJ, Hwang ES, Mittendorf EA, Shi W, Zhang Z, Ho AY.

Cancer. 2018 Feb 1;124(3):482-490. doi: 10.1002/cncr.31080. Epub 2017 Nov 7.

PMID:
29112227
12.

Temporal Trends in Postmastectomy Radiation Therapy and Breast Reconstruction Associated With Changes in National Comprehensive Cancer Network Guidelines.

Frasier LL, Holden S, Holden T, Schumacher JR, Leverson G, Anderson B, Greenberg CC, Neuman HB.

JAMA Oncol. 2016 Jan;2(1):95-101. doi: 10.1001/jamaoncol.2015.3717. Erratum in: JAMA Oncol. 2016 Jan;2(1):146.

13.

Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.

Cabioglu N, Hunt KK, Sahin AA, Kuerer HM, Babiera GV, Singletary SE, Whitman GJ, Ross MI, Ames FC, Feig BW, Buchholz TA, Meric-Bernstam F.

Ann Surg Oncol. 2007 Apr;14(4):1458-71. Epub 2007 Jan 28.

PMID:
17260108
14.

Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons.

Dick AW, Sorbero MS, Ahrendt GM, Hayman JA, Gold HT, Schiffhauer L, Stark A, Griggs JJ.

J Natl Cancer Inst. 2011 Jan 19;103(2):92-104. doi: 10.1093/jnci/djq499. Epub 2011 Jan 3.

15.
16.

Postmastectomy radiation therapy for T3N0: a SEER analysis.

Johnson ME, Handorf EA, Martin JM, Hayes SB.

Cancer. 2014 Nov 15;120(22):3569-74. doi: 10.1002/cncr.28865. Epub 2014 Jul 1.

17.

Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.

Sahoo S, Recant WM, Jaskowiak N, Tong L, Heimann R.

Breast J. 2005 Jul-Aug;11(4):242-7.

PMID:
15982389
18.

Post mastectomy radiotherapy in breast cancer: a survey of current United Kingdom practice.

Mallon PT, McIntosh SA.

J BUON. 2012 Apr-Jun;17(2):245-8.

PMID:
22740200
19.

Effect of Postmastectomy Radiation on Survival of AJCC pN2/N3 Breast Cancer Patients.

Shi Z, Peddi P, Burton G, Mills G, Shi R.

Anticancer Res. 2016 Jan;36(1):261-9.

PMID:
26722052
20.

Post-Mastectomy Radiation Therapy for Invasive Lobular Carcinoma: A Comparative Utilization and Outcomes Study.

Stecklein SR, Shen X, Mitchell MP.

Clin Breast Cancer. 2016 Aug;16(4):319-26. doi: 10.1016/j.clbc.2016.02.001. Epub 2016 Feb 11.

PMID:
26943990

Supplemental Content

Support Center